(Date:11/6/2009)... Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("...ted results from a Phase II study of intravenous R... the lung in a poster presentation at the 15th Ann...d in Miami Beach, Florida, from November 5th to 7t...tudy of Intravenous REOLYSIN (Wild-type Reovirus) ...
(Date:11/6/2009)...head’s 2010 Personalized Medicine Partnershi...ary 22-24, 2010 in Philadelphia, has been announce...key issues in forming partnerships and engage the ... Minneapolis, MN (PRWEB) Novembe...0 Personalized Medicine Partnerships Conference , ...
(Date:11/5/2009)...rstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today an...r ended September 30, 2009. GenVec reported a net ...ee months ended September 30, 2009 compared to a n...omparable quarter of 2008. For the nine months end... million ($0.15 per share), compared to a net loss...
(Date:11/5/2009)... DSM Pharmaceutical Products today announced that ... Saint Jean D,Illac, France, where DSM will be the...for Galenix commercial products on a global basis....s development opportunities co-marketing Galenix d...f Galenix in drug product development and clinical...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3...ider of room-temperature biosample transport, stor...ease today of GenConnect 3.2, the newest version o... Highlights of the release include a strategic lic...ted seamlessly into third-party informatics offeri...t enables scalable enterprise-wide deployment that...
...General Meeting of Syngenta AG on 21 April 2009, t...by the Board of Directors. , , Shareholders appr...ness year 2008, an increase of 25% over the previo... the share capital to CHF 9,459,984.90 through the...ny repurchased in 2008 within the scope of the app...
...ovide sustained tumor exposure to platinum and pro...city observed in the clinic - , , DALLAS, April 2...ard: ACCP) announced today that its collaborator...preclinical data on its lead anticancer compound, ...cer Research (AACR) Annual Meeting taking place Ap...
Other Biology Technology:GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2 2GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2 3Syngenta holds Annual General Meeting 2Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting 2Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting 3Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting 47500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
Safety Glasses Dispensers from Terra Universal, Inc.
Apparel Dispenser from Terra Universal, Inc.
...A expression profiling and built on the flexible a... platform. These microarrays are available as part...g Service. Probe Content The Mammals microRNA M... unique mature sequences). The comprehensive probe...
Biology Products: